Chapel Hill, NC, United States of America

Juan Li

This inventor holds 8 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: The University of North Carolina at Chapel Hill, Bamboo Therapeutics, Inc.. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juan Li. Retrieved from https://idiyas.com/inventor/juan-li-3n5r4euh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 5)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 9)

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

8 out of 1,327

The University of North Carolina at Chapel Hill

patents

2 out of 3

Bamboo Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12410441 - Synthetic liver-tropic adeno-associated virus capsids and uses thereof (2025-09-09),

2. 12257321 - Optimized mini-dystrophin genes and expression cassettes and their use (2025-03-25),

3. 12209263 - Optimized human clotting factor IX gene expression cassettes and their use (2025-01-28),

4. 12209251 - Modified adeno-associated virus 5 capsids and uses thereof (2025-01-28),

5. 12116398 - Optimized human clotting factor VIII gene expression cassettes and their use (2024-10-15),

6. 11547765 - Optimized mini-dystrophin genes and expression cassettes and their use (2023-01-10),

7. 11530402 - Optimized human clotting factor IX gene expression cassettes and their use (2022-12-20),

8. 10308705 - Optimized human clotting factor VIII gene expression cassettes and their use (2019-06-04),

Title: Innovations and Contributions of Inventor Juan Li

Introduction

Juan Li is a prominent inventor based in Chapel Hill, NC, known for his significant contributions to the field of biotechnology. With a total of 8 patents to his name, he has made remarkable advancements in the development of viral vectors and gene therapies.

Latest Patents

One of Juan Li's latest patents is titled "Synthetic liver-tropic adeno-associated virus capsids and uses thereof." This invention focuses on synthetic adeno-associated virus capsids that are specifically targeted to the liver. The patent outlines methods for using these vectors to achieve liver-specific expression and effectively transduce human primary hepatocytes and cell lines. Another notable patent is "Optimized mini-dystrophin genes and expression cassettes and their use." This invention involves polynucleotides encoding mini-dystrophin proteins, along with viral vectors that facilitate the delivery of mini-dystrophin to cells or subjects.

Career Highlights

Juan Li has worked with esteemed institutions such as the University of North Carolina at Chapel Hill and Bamboo Therapeutics, Inc. His work has been instrumental in advancing gene therapy techniques and improving treatment options for various diseases.

Collaborations

Throughout his career, Juan Li has collaborated with notable colleagues, including Xiao Xiao and Zhenhua Yuan. These partnerships have contributed to the success of his research and innovations.

Conclusion

Juan Li's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in gene therapy and targeted treatments.

Profile summary based on public USPTO records.